1. Home
  2. HRTG vs GHRS Comparison

HRTG vs GHRS Comparison

Compare HRTG & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Insurance Holdings Inc.

HRTG

Heritage Insurance Holdings Inc.

HOLD

Current Price

$28.64

Market Cap

898.0M

Sector

Finance

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$15.04

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRTG
GHRS
Founded
2012
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
898.0M
1.0B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
HRTG
GHRS
Price
$28.64
$15.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$33.50
$40.33
AVG Volume (30 Days)
344.0K
189.8K
Earning Date
06-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
214.43
N/A
EPS
6.32
N/A
Revenue
$847,330,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.89
N/A
P/E Ratio
$4.50
N/A
Revenue Growth
3.71
N/A
52 Week Low
$13.28
$7.98
52 Week High
$31.98
$19.51

Technical Indicators

Market Signals
Indicator
HRTG
GHRS
Relative Strength Index (RSI) 62.12 46.63
Support Level $25.47 $12.04
Resistance Level $29.18 $16.22
Average True Range (ATR) 1.27 0.96
MACD 0.16 -0.07
Stochastic Oscillator 89.40 31.13

Price Performance

Historical Comparison
HRTG
GHRS

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: